Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma

Reliable biomarkers for renal cell carcinoma (RCC) have yet to be determined. Circulating tumor DNA (ctDNA) is an emerging resource to detect and monitor molecular characteristics of various tumors. The present study aims to clarify the clinical utility of ctDNA for RCC. Fifty‐three patients histolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Yoshiyuki, Uemura, Motohide, Fujita, Masashi, Maejima, Kazuhiro, Koh, Yoko, Matsushita, Makoto, Nakano, Kosuke, Hayashi, Yujiro, Wang, Cong, Ishizuya, Yu, Kinouchi, Toshiro, Hayashi, Takuji, Matsuzaki, Kyosuke, Jingushi, Kentaro, Kato, Taigo, Kawashima, Atsunari, Ujike, Takeshi, Nagahara, Akira, Fujita, Kazutoshi, Imamura, Ryoichi, Nakagawa, Hidewaki, Nonomura, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361573/
https://www.ncbi.nlm.nih.gov/pubmed/30536551
http://dx.doi.org/10.1111/cas.13906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361573/
https://www.ncbi.nlm.nih.gov/pubmed/30536551
http://dx.doi.org/10.1111/cas.13906

Ejemplares similares